Abstract: The purpose of the present invention is to provide a novel medical application using pluripotent stem cells in regenerative medicine. The present invention provides a cell formulation and pharmaceutical composition that are for amelioration and therapy for frequent urination and bladder pain caused by the inflammation of the bladder and that contain SSEA-3 positive pluripotent stem cells isolated from cultured mesenchymal cells or a mesenchymal tissue of a living organism. The cell formulation according to the present invention is considered to be based on a mechanism in which, for example, Muse cells are administered against interstitial cystitis having the abovementioned disorders to be successfully engrafted into affected bladder tissue, whereby the disorders are ameliorated and treated.

Abstract: An image processing apparatus for performing correction for each frame group including a predetermined number of frames into which video data is divided includes a decoding unit configured to obtain a corrected frame group by correcting a second frame group, which is a frame group continuous with a first frame group in time, using a feature quantity of the first frame group. The decoding unit performs the correction so that subjective image quality based on a relationship between the second frame group and a frame group subsequent to the second frame group in time is increased and so that a predetermined classifier classifies that a frame group in which the second frame group is concatenated with the frame group subsequent to the second frame group in time is the same as a frame group in which the corrected frame group is concatenated with a corrected frame group obtained by correcting the frame group subsequent to the second frame group in time.

Abstract: The purpose of the present invention is to provide a novel medical application of pluripotent stem cells (muse cells) in regeneration medicine. The present invention provides a cell preparation and a pharmaceutical composition which are for amelioration and treatment of brain disorders resulting from fetal growth retardation, such as abnormal motor quality or abnormal neurological development, and which contain SSEA-3 positive pluripotent stem cells isolated from a mesenchymal tissue from a live body or cultured mesenchymal cells. It is assumed that this cell preparation is based on a mechanism where muse cells that are administered to objects having the disorders are engrafted on an impaired brain tissue, thereby ameliorating or treating the disorders.

Abstract: A coding apparatus is a coding apparatus for coding an original image and includes: a division section that divides the original image into blocks that are a plurality of areas to acquire the plurality of blocks; a determination section that, for each of the blocks, determines whether or not to determine the block as an interpolation target; and a substitution section that substitutes a value of a pixel included in the block determined as the interpolation target, with a value that decreases a code amount of the block determined as the interpolation target. The determination section determines whether or not to determine the area that is a target of the determination as an area that is the interpolation target, using an evaluation based on an accuracy of prediction of an image of the block by intra prediction or inter prediction and a degree of the area that is the interpolation target being a generated one.

Abstract: An encoding device includes: an association processing unit that associates first encoded data which is encoded data of an original image with second encoded data which is encoded data of a decoded image which is a result of decoding of the encoded data of the original image; and an encoding unit that encodes, based on the result of associating the first encoded data with the second encoded data, a target image which is an image to be encoded.

Abstract: The purpose of the present invention is to provide a novel medical application of pluripotent stem cells (muse cells) in regeneration medicine. The present invention provides a cell preparation and a pharmaceutical composition which are for amelioration and treatment of brain disorders resulting from fetal growth retardation, such as abnormal motor quality or abnormal neurological development, and which contain SSEA-3 positive pluripotent stem cells isolated from a mesenchymal tissue from a live body or cultured mesenchymal cells. It is assumed that this cell preparation is based on a mechanism where muse cells that are administered to objects having the disorders are engrafted on an impaired brain tissue, thereby ameliorating or treating the disorders.

Abstract: The present invention addresses the problem of providing a novel use of pluripotent stem cells (Muse cells) for medical purposes in regenerative medicine. The present invention provides a cell preparation and a pharmaceutical composition both for ameliorating and treating perinatal brain damage including learning disability and motor disability, each of the cell preparation and the pharmaceutical composition containing SSEA-3-positive pluripotent stem cells isolated from a mesenchymal tissue collected from a living body or cultured mesenchymal cells. The cell preparation according to the present invention relies on a mechanism that Muse cells are administered to a subject having the above-mentioned damage to cause the engraftment of the Muse cells in a damaged brain tissue, thereby ameliorating and treating the damage.

Abstract: The purpose of the present invention is to provide a novel medical use of pluripotent stem cells (Muse cells) in the regenerative medicine area. Provided are a cell preparation and a medicinal composition for ameliorating and treating chronic lung disease in newborns, said cell preparation and medicinal composition comprising SSEA-3-positive pluripotent stem cells isolated from a mesenchymal tissue in a living body or cultured mesenchymal cells. The cell preparation according to the present invention is based on a mechanism whereby the aforesaid disease is ameliorated and treated by administering Muse cells to a subject suffering from the disease and engrafting the cells in lung tissues.